{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:02:18Z","timestamp":1791259338253,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008185.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T00:00:00Z","timestamp":1454630400000}}],"reference-count":37,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008185.pub4","type":"journal-article","created":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T23:24:06Z","timestamp":1454628246000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)"],"prefix":"10.1002","volume":"2016","author":[{"given":"Edina MK","family":"da Silva","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo; Emergency Medicine and Evidence Based Medicine; Rua Borges Lagoa 564 cj 64 Vl. Clementino S\u00e3o Paulo S\u00e3o Paulo Brazil 04038-000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Wany Louzada","family":"Strufaldi","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo; S\u00e3o Paulo S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regis B","family":"Andriolo","sequence":"additional","affiliation":[{"name":"Universidade do Estado do Par\u00e1; Department of Public Health; Travessa Perebebu\u00ed, 2623 Bel\u00e9m Par\u00e1 Brazil 66087-670"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laercio A","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo; Department of Urology; Rua Doutor Nicolau de Sousa Queiros, 629. Ap.130B S\u00e3o Paulo S\u00e3o Paulo Brazil 04105002"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,2,5]]},"reference":[{"issue":"Suppl 1","key":"10.1002\/14651858.CD008185.pub4-BIB0001|cit1","first-page":"116","article-title":"\u00a0Long-term weekly dosing of idursulfase in the treatment of mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]","volume":"30","author":"Beck","year":"2007","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"2","key":"10.1002\/14651858.CD008185.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/GIM.0b013e3181fea459","article-title":"Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genetics in Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008185.pub4-BIB0003|cit3","first-page":"28","article-title":"Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]","volume":"29","author":"Muenzer","year":"2006","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"8","key":"10.1002\/14651858.CD008185.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genetics in Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008185.pub4-BIB0005|cit5","first-page":"S7","article-title":"Clinical study of enzyme replacement therapy with idursulfase","volume":"44","author":"Guti\u00e9rrez-Solana","year":"2007","journal-title":"Revista de Neurologia"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008185.pub4-BIB0006|cit6","first-page":"188","article-title":"The long-term experience of enzyme replacement therapy for Hunter syndrome (MPS II) [abstract]","volume":"28","author":"Muenzer","year":"2005","journal-title":"Journal of Inherited Metabolic Disorder"},{"issue":"3","key":"10.1002\/14651858.CD008185.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ymgme.2006.09.001","article-title":"A phase I\/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)","volume":"90","author":"Muenzer","year":"2007","journal-title":"Molecular Genetics and Metabolism."},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008185.pub4-BIB0008|cit8","first-page":"144","article-title":"The 12-month experience of enzyme replacement for mucopolysaccharidosis II (Hunter syndrome) [abstract]","volume":"26","author":"Muenzer","year":"2003","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"1","key":"10.1002\/14651858.CD008185.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/gim.2015.36","article-title":"A phase I\/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II","volume":"18","author":"Muenzer","year":"2016","journal-title":"Genetics in Medicine"},{"key":"10.1002\/14651858.CD008185.pub4-BIB0010|cit10","first-page":"S260, Abstract","article-title":"Phase I\/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter Syndrome) [abstract]","volume":"36 Suppl 2","author":"Sohn","year":"2013","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1002\/14651858.CD008185.pub4-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1172-8-42","article-title":"Phase I\/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Sohn","year":"2013","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"2","key":"10.1002\/14651858.CD008185.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ymgme.2014.08.009","article-title":"Safety and efficacy of enzyme replacement therapy with idursulfase beta in children aged younger than 6 years with Hunter syndrome","volume":"114","author":"Sohn","year":"2015","journal-title":"Molecular Genetics and Metabolism"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008185.pub4-BIB0013|cit13","first-page":"130","article-title":"A clinical trial of idursulfase in Hunter syndrome patients 5 years old and younger [abstract]","volume":"31","author":"Tylki-Szymanska","year":"2008","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1002\/14651858.CD008185.pub4-BIB0014|cit14","unstructured":"NCT02055118 A controlled, randomized, two-arm, open-label, assessor-blinded, multicenter study of intrathecal idursulfase-IT administered in conjunction with elaprase \u00ae in pediatric patients with Hunter syndrome and early cognitive impairment https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02055118"},{"issue":"6","key":"10.1002\/14651858.CD008185.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejmg.2010.07.013","article-title":"First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: Case observations from the Hunter Outcome Survey (HOS)","volume":"53","author":"Alcalde-Mart\u00edn","year":"2010","journal-title":"European Journal of Medical Genetics"},{"issue":"1","key":"10.1002\/14651858.CD008185.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","author":"American Thoracic Society","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"6","key":"10.1002\/14651858.CD008185.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/clinchem\/38.6.803","article-title":"Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue","volume":"38","author":"Jong","year":"1992","journal-title":"Clinical Chemistry"},{"issue":"1","key":"10.1002\/14651858.CD008185.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"7414","key":"10.1002\/14651858.CD008185.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008185.pub4-BIB0020|cit20","unstructured":"Higgins JPT Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD008185.pub4-BIB0021|cit21","unstructured":"Higgins JPT Deeks JJ Altman DG Chpater 16: Special topics in statistics. Intention to treat issues. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD008185.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s10545-009-1119-7","article-title":"Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS)","volume":"32","author":"Jones","year":"2008","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"1","key":"10.1002\/14651858.CD008185.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ymgme.2013.03.001","article-title":"The effect of idursulfase on growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS)","volume":"109","author":"Jones","year":"2013","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1002\/14651858.CD008185.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0076-6879(82)83052-8","article-title":"Enzymic diagnosis of the genetic mucopolysaccharide storage disorders","volume":"83","author":"Kresse","year":"1982","journal-title":"Methods in Enzymology"},{"issue":"2","key":"10.1002\/14651858.CD008185.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1542\/peds.2007-1350","article-title":"Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome)","volume":"121","author":"Martin","year":"2008","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD008185.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD008185.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/GIM.0b013e3181fea459","article-title":"Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genetics in Medicine"},{"key":"10.1002\/14651858.CD008185.pub4-BIB0028|cit28","unstructured":"National Horizon Scanning Centre New and Emerging Technology Briefing: Iduronate-2-sulfatase for Hunter Syndrome The University of Birmingham 2005"},{"key":"10.1002\/14651858.CD008185.pub4-BIB0029|cit29","first-page":"3421","article-title":"The mucopolysaccharidoses","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Neufeld","year":"2001"},{"issue":"1","key":"10.1002\/14651858.CD008185.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10545-010-9215-2","article-title":"Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II","volume":"34","author":"Schulze-Frenking","year":"2011","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"4","key":"10.1002\/14651858.CD008185.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.pediatrneurol.2004.10.009","article-title":"\u00a0Mucopolysaccharidosis type II in females: case report and review of literature","volume":"32","author":"Tuschl","year":"2005","journal-title":"Pediatric Neurology"},{"key":"10.1002\/14651858.CD008185.pub4-BIB0032|cit32","unstructured":"Vellodi A Wraith JE Cleary M Ramaswami U Lavery C Jessop E Guidelines for the investigation and management of patients with mucopolysaccharidosis type II www.specialisedservices.nhs.uk\/library\/23\/Guidelines_for_Mucopolysaccharidosis_Type_II.pdf (accessed September 2009)"},{"issue":"3","key":"10.1002\/14651858.CD008185.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2008","journal-title":"European Journal of Pediatrics"},{"issue":"497","key":"10.1002\/14651858.CD008185.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1651-2227.2008.00661.x","article-title":"Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II","volume":"97","author":"Wraith","year":"2008","journal-title":"Acta Paediatrica. Supplementum"},{"issue":"4","key":"10.1002\/14651858.CD008185.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1469-8749.1983.tb13794.x","article-title":"The natural history of the severe form of Hunter's syndrome: a study based on 52 cases","volume":"25","author":"Young","year":"1983","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"11","key":"10.1002\/14651858.CD008185.pub4-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008185.pub2","article-title":"Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)","author":"Silva","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD008185.pub4-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008185.pub3","article-title":"Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)","author":"Silva","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD008185.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T18:47:20Z","timestamp":1641408440000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008185.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,5]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008185.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,5]]}}}